Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis

The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.

Nestlé Partners with DBV to Develop Milk Allergy Test

The world's largest food business forays into allergy diagnostic services to help sell infant formula.

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the AAAAI Conference

We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

FDA Provides Primer on Current State of Allergy Immunotherapies

We provide a summary for individuals new to the world of food allergies and therapies under investigation.
Oval Auto-Injector

Medical Device Company Tests Compact Auto-Injector Design

The firm is currently in the early stages of testing the design of a new, compact auto-injector which the company estimates may hit the UK market in 2019.

Patent Issued for Innovative Auto-Injector Mechanism

Does this portend an auto-injector with a longer shelf-life, impervious to temperature changes, and the size of a USB thumb-drive that could be carried on a key chain?

Breakthrough Food Allergy Therapies and the Big Business Behind Them

What it means to be a breakthrough therapy, who is developing them, how they work, and the (big) business drivers behind them.

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.

Peanut Patch Receives FDA’s Breakthrough Therapy Designation

The Viaskin Peanut patch received the BT designation after a positive Phase IIb trial.

Connect with Us

27,828FansLike
85FollowersFollow
3,884FollowersFollow
30SubscribersSubscribe